Replies to post #526 on China Medicine Corporation (CHME)

[funnyG986]

CHME HEADING TO $0.4 for 1st stop

[funnyG986]

CHME document from China Lawyer back in 2016 showing CEO Yang Senshan bought 3.3M shares from two other co-founders at a price of Chinese Yuan 2.6, which is around $0.4 USD

Link to the lawyer document
http://pdfcdn2.ipo3.com/quasi_notices/upload/201606/30/42305_1467274429_216024.pdf

Chinese copy see Page 59


Google translate to English

(3) Liu Minhua, Liu Junhua exit CMC
According to the "United States Legal Opinion", October 25, 2015, Liu Minhua, Liu Junhua and Hongsheng (incense
Hong Kong Investment Co., Ltd. (hereinafter referred to as "Hongsheng Company") signed the "Share Purchase and Transfer Agreement", Liu Min
Hua, Liu Junhua holds all of its shares in CMC (2,662,000 shares and 653,000 shares respectively)
RMB 2.6 yuan price transfer to the Hongsheng company.
According to Hongsheng's "Business Registration Certificate", "Annual Report" and other information, Hongsheng company has issued
The shares are 10,000 ordinary shares and are held by HONG SHENG INVESTMENT INC. according to
HONG SHENG INVESTMENT INC. 'S company registration information, board of directors and other information, HONG
SHENG INVESTMENT INC. Is the shareholder of Yang Sen Shan.
According to Yang Senshan, Liu Minhua, Liu Junhua provided "online bank back to the single", three issued by the statement and
Commitment, Yangsen Hill has been paid to Liu Minhua, Liu Junhua transferee CMC shares of the price.
After the completion of the equity transfer, Liu Minhua, Liu Junhua no longer hold CMC shares.
Kang Zuen Group will hold 100% stake in Kang Zuen foreign transfer and Liu Minhua, Liu Junhua will hold
CMC shares after the transfer, Kang Zaien red chip structure all cleared.